Yellow fever 17D virus: Pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein

Virology

Volumn 327, Issue 1, 2004, Pages 41-49

  Vlaycheva, Leonssia ^a   Nickells, Michael ^a   Droll, Deborah A ^a   Chambers, Thomas J ^a,b  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^b S Louis Univ Hlth Sciences Center   (United States)

Author keywords

Cell penetration; E protein; Yellow fever 17D virus

Indexed keywords

ALANINE; ASPARAGINE; GLYCINE; LYSINE; VALINE; VIRUS ENVELOPE PROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL ADHESION; CELL SURFACE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HYDROPHOBICITY; LIGAND BINDING; MEMBRANE FUSION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PURIFICATION; REVERTANT; VERO CELL; VIROGENESIS; VIRUS ADSORPTION; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS MUTATION; YELLOW FEVER FLAVIVIRUS;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; DEFECTIVE VIRUSES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PLAQUE ASSAY; SUPPRESSION, GENETIC; VERO CELLS; VIRAL ENVELOPE PROTEINS; YELLOW FEVER VIRUS;

FLAVIVIRUS; YELLOW FEVER VIRUS (STRAIN 17D);

EID: 4344633729     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.06.015     Document Type: Article

References (26)

1. Anderson R. Manipulation of cell surface molecules by flaviviruses. Chambers T.J., Monath T.P. The Flaviviruses: Structure, Replication and Evolution. Adv. Virus Res. vol. 59:2003;230-274 Elsevier/Academic Press, London
2. Beasley D.W., Aaskov J.G. Epitopes on the dengue 1 virus envelope protein recognized by neutralizing IgM monoclonal antibodies. Virology. 279:2001;447-458
3. Bhardwaj S., Holbrook M., Shope R.E., Barrett A.D.T., Watowich S.J. Biophysical characterization and vector-specific antagonist activity of domain III of the tick-borne flavivirus envelope protein. J. Virol. 75:2001;4002-4007
4. Bressanelli S., Stiasny K., Allison S.L., Stura E.A., Duquerroy S., Lescar J., Heinz F.X., Rey F.A. Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J. 23:2004;728-738. (Electronic publication 2004 Feb 12)
5. Cecilia D., Gould E.A. Nucleotide changes responsible for loss of neuroinvasiveness in Japanese encephalitis virus neutralization-resistant mutants. Virology. 181:1991;70-77
6. Chen Y., Maguire T., Hileman R.E., Fromm J.R., Esko J.D., Linhardt R.J., Marks R.E. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat. Med. 3:1997;866-871
7. Crill W.D., Roehrig J.T. Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J. Virol. 75:2001;7769-7773
8. Germi R., Crance J.M., Garin D., Guimet J., Lortat-Jacob H., Ruigrok R.W., Zarski J.P., Drouet E. Heparan sulfate-mediated binding of infectious dengue virus type 2 and yellow fever virus. Virology. 292:2002;162-168
9. Hasegawa H., Yoshida M., Shiosaka T., Fijita S., Kobayashi Y. Mutations in the envelope protein of Japanese encephalitis virus affect entry into cultured cells and virulence in mice. Virology. 191:1992;158-165
10. Heinz F.X., Allison S.A. Structures and mechanisms in flavivirus fusion. Adv. Virus Res. 55:2000;231-269
11. Hurrelbrink R.J., McMinn P.C. Attenuation of Murray Valley encephalitis virus by site-directed mutagenesis of the hinge and putative receptor-binding regions of the envelope protein. J. Virol. 75:2001;7692-7702
12. Jennings A.D., Gibson C.A., Miller B.R., Mathews J.H., Mitchell C.J., Roehrig J.T., Wood D.J., Taffs F., Sil B.K., Whitby S.N., et al. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J. Infect. Dis. 169:1994;512-518
13. Lee E., Lobigs M. Substitutions at the putative receptor-binding site of an encephalitis flavivirus alter virulence and host cell tropism and reveal a role for glycosaminoglycan in entry. J. Virol. 74:2000;8867-8875
14. Lee E., Weir R.C., Dalgarno L. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Virology. 232:1997;281-290
15. Mandl C., Allison S., Holzmann H., Meixner T., Heinz F.X. Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor-binding site. J. Virol. 74:2000;9601-9609
16. Mandl C.W., Kroschewski H., Allison S.L., Kofler R., Holzmann H., Meixner T., Heinz F.X. Adaptation of tick-borne encephalitis virus to BHK-21 cells results in the formation of multiple heparan sulfate binding sites in the envelope protein and attenuation in vitro. J. Virol. 75:2001;5627-5637
17. Modis Y., Ogata S., Clements D., Harrison S.C. A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 100:2003;6986-6991. (Electronic publication 2003 May 20)
18. Modis Y., Ogata S., Clements D., Harrison S.C. Structure of the dengue virus envelope protein after membrane fusion. Nature. 427:2004;313-319
19. Monath T.P., Arroyo J., Levenbook I., Zhang Z.X., Catalan J., Draper K., Guirakhoo F. Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccines. J. Virol. 76:2002;1932-1943
20. Ni H., Ryman K.D., Wang H., Saeed M.F., Hull R., Wood D., Minor P.D., Watowich S.J., Barrett A.D.T. Interaction of yellow fever virus French neurotropic vaccine strain with monkey brain: characterization of monkey brain membrane receptor escape variants. J. Virol. 74:2000;2903-2906
21. Nickells M., Chambers T.J. Neuroadapted yellow fever 17D: determinants in the envelope (E) protein govern neuroinvasiveness for SCID mice. J. Virol. 77:2003;12232-12242
22. Rey F.A., Heinz F.X., Mandl C., Kunz C., Harrison S.C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 375:1995;291-298
23. Rice C.M. Flaviviridae: the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M., et al. Fields Virology. 3rd ed.:1996;931-960 Lippincott-Raven, Philadelphia, PA
24. Rice C.M., Grakoui A., Galler R., Chambers T.J. Transcription of infectious yellow fever RNA from full-length cDNA templates produced by in vitro ligation. New Biol. 1:1989;85-96
25. Ryman K.D., Ledger T.N., Campbell G.A., Watowich S.J., Barrett A.D.T. Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice. Virology. 244:1998;59-65
26. Vlaycheva L., Chambers T.J. Neuroblastoma cell-adapted yellow fever 17D: characterization of a viral variant associated with persistent infection and decreased virus spread. J. Virol. 76:2002;6172-6184